Our founder's roots are in angel investment and much of his time over the last 16 years has been spent in helping launch and fund over 50 early-stage life science companies in the US and China. Now, these efforts are continuing to expand through two major efforts.
The VIC*ChinaBio Incubator is a joint effort between ChinaBio and US investor, VIC Technology Venture Development. With over 4,000 m2 of offices and labs centrally located between Shenzhen, Guangzhou and Hong Kong, the VIC*ChinaBio Incubator is funding and supporting innovative life science companies in the US and EU with a strategic focus on China.
For more information, see VIC*ChinaBio Incubator
BioPacific Investors' angel investments are squarely focused on US companies with innovative products and technologies that have future applicability to China. With a strong emphasis on medical device and diagnostics, but also novel therapeutic development, BioPacific has funded companies with technology from Stanford, Harvard, MIT, and other major universities in the US.
For more information, see BioPacific Investors